Difference between revisions of "CMV colitis"

(Text replacement - "==Diagnosis==" to "==Evaluation==")
Line 6: Line 6:
  
 
==Clinical Features==
 
==Clinical Features==
*Fever
+
*[[Fever]]
 
*Anorexia
 
*Anorexia
 
*Malaise
 
*Malaise
Line 12: Line 12:
 
*Dehydration
 
*Dehydration
 
*Abdominal pain
 
*Abdominal pain
*Abdominal distention
+
*Abdominal distention, [[constipation]]
*Nausea
+
*[[Nausea/vomiting]]
*Vomiting
+
*Chronic watery [[diarrhea]]
*Chronic watery diarrhea
 
 
*Bloody diarrhea
 
*Bloody diarrhea
*Constipation
 
 
*Worsening symptoms of inflammatory bowel disease
 
*Worsening symptoms of inflammatory bowel disease
  
Line 28: Line 26:
  
 
==Management==
 
==Management==
 +
{{CMV colitis treatment}}
  
 
==Disposition==
 
==Disposition==
{{CMV colitis treatment}}
 
 
==See Also==
 
==See Also==
 
*[[Cytomegalovirus (CMV) infection]]
 
*[[Cytomegalovirus (CMV) infection]]

Revision as of 00:03, 26 February 2017

Background

  • CMV is part of the Herpesviridae family
  • 50-80% of the world's population is seropositive for CMV
  • Causes a mild or undetectable infection in immunocompetent hosts
  • Severe systemic illness is found in immunosuppressed hosts

Clinical Features

  • Fever
  • Anorexia
  • Malaise
  • Weight loss
  • Dehydration
  • Abdominal pain
  • Abdominal distention, constipation
  • Nausea/vomiting
  • Chronic watery diarrhea
  • Bloody diarrhea
  • Worsening symptoms of inflammatory bowel disease

Differential Diagnosis

Colitis

CMV Diseases

Evaluation

Management

  • Ganciclovir 5mg/kg IV q12hrs x 21 days (or until resolution of symptoms)
  • Foscarnet 90mg/kg IV q12hrs daily x 21 days (or until resolution of symptoms)

Disposition

See Also

External Links

References